CLINICAL_TRIALS
trial_result
· 2021-05-11
Clinical Trial Update: An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps [Phase 3]
Summary
An extension study of omalizumab in chronic rhinosinusitis with nasal polyps completed Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Nasal Polyps, Chronic Rhinosinusitis | Phase 3 | Status: COMPLETED | Results posted: 2021-05-11